168 related articles for article (PubMed ID: 25682862)
1. Prognostic significance of aminopeptidase-N (CD13) in hepatoblastoma.
Saida S; Watanabe K; Kato I; Fujino H; Umeda K; Okamoto S; Uemoto S; Hishiki T; Yoshida H; Tanaka S; Adachi S; Niwa A; Nakahata T; Heike T
Pediatr Int; 2015 Aug; 57(4):558-66. PubMed ID: 25682862
[TBL] [Abstract][Full Text] [Related]
2. Ectopeptidases are differentially expressed in hepatocellular carcinomas.
Röcken C; Carl-McGrath S; Gräntzdörffer I; Mantke R; Roessner A; Lendeckel U
Int J Oncol; 2004 Mar; 24(3):487-95. PubMed ID: 14767532
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of aminopeptidase N in non-small cell lung cancer.
Tokuhara T; Hattori N; Ishida H; Hirai T; Higashiyama M; Kodama K; Miyake M
Clin Cancer Res; 2006 Jul; 12(13):3971-8. PubMed ID: 16818694
[TBL] [Abstract][Full Text] [Related]
4. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.
Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K
Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992
[TBL] [Abstract][Full Text] [Related]
5. Hepatoblastomas exhibit marked
Rivas MP; Aguiar TFM; Maschietto M; Lemes RB; Caires-Júnior LC; Goulart E; Telles-Silva KA; Novak E; Cristofani LM; Odone V; Cypriano M; de Toledo SRC; Carraro DM; Escobar MQ; Lee H; Johnston M; da Costa CML; da Cunha IW; Tasic L; Pearson PL; Rosenberg C; Timchenko N; Krepischi ACV
Tumour Biol; 2020 Dec; 42(12):1010428320977124. PubMed ID: 33256542
[TBL] [Abstract][Full Text] [Related]
6. High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma.
Hiyama E; Yamaoka H; Matsunaga T; Hayashi Y; Ando H; Suita S; Horie H; Kaneko M; Sasaki F; Hashizume K; Nakagawara A; Ohnuma N; Yokoyama T
Br J Cancer; 2004 Aug; 91(5):972-9. PubMed ID: 15280920
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor GATA4 associates with mesenchymal-like gene expression in human hepatoblastoma cells.
Soini T; Eloranta K; Pihlajoki M; Kyrönlahti A; Akinrinade O; Andersson N; Lohi J; Pakarinen MP; Wilson DB; Heikinheimo M
Tumour Biol; 2018 Jul; 40(7):1010428318785498. PubMed ID: 30074440
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma.
Ikeda N; Nakajima Y; Tokuhara T; Hattori N; Sho M; Kanehiro H; Miyake M
Clin Cancer Res; 2003 Apr; 9(4):1503-8. PubMed ID: 12684426
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic and prognostic value of SALL4 in hepatoblastoma.
Zhou S; Venkatramani R; Gomulia E; Shillingford N; Wang L
Histopathology; 2016 Nov; 69(5):822-830. PubMed ID: 27252091
[TBL] [Abstract][Full Text] [Related]
11. MT1G hypermethylation: a potential prognostic marker for hepatoblastoma.
Sakamoto LH; DE Camargo B; Cajaiba M; Soares FA; Vettore AL
Pediatr Res; 2010 Apr; 67(4):387-93. PubMed ID: 20032811
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors.
Yamaoka H; Ohtsu K; Sueda T; Yokoyama T; Hiyama E
Oncol Rep; 2006 Mar; 15(3):551-6. PubMed ID: 16465411
[TBL] [Abstract][Full Text] [Related]
13. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C
Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016
[TBL] [Abstract][Full Text] [Related]
14. Primary malignant epithelial tumors of the liver in children: a study of DNA content and oncogene expression.
Zerbini MC; Sredni ST; Grier H; Cristofani LM; Latorre MR; Hollister KA; Alves VA; Weinberg DS; Perez-Atayde AR
Pediatr Dev Pathol; 1998; 1(4):270-80. PubMed ID: 10463288
[TBL] [Abstract][Full Text] [Related]
15. Hepatoblastoma: DNA nuclear content, proliferative indices, and pathology.
Rugge M; Sonego F; Pollice L; Perilongo G; Guido M; Basso G; Ninfo V; Pennelli N; Gambini C; Guglielmi M; Fabiano A; Leandro G; Keeling JW
Liver; 1998 Apr; 18(2):128-33. PubMed ID: 9588772
[TBL] [Abstract][Full Text] [Related]
16. CD13 (aminopeptidase N) can associate with tumor-associated antigen L6 and enhance the motility of human lung cancer cells.
Chang YW; Chen SC; Cheng EC; Ko YP; Lin YC; Kao YR; Tsay YG; Yang PC; Wu CW; Roffler SR
Int J Cancer; 2005 Aug; 116(2):243-52. PubMed ID: 15812828
[TBL] [Abstract][Full Text] [Related]
17. Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.
Zhang Q; Wang J; Zhang H; Zhao D; Zhang Z; Zhang S
J Cancer Res Ther; 2015; 11(1):223-8. PubMed ID: 25879366
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma.
Kawamura J; Shimada Y; Kitaichi H; Komoto I; Hashimoto Y; Kaganoi J; Miyake M; Yamasaki S; Kondo K; Imamura M
Hepatogastroenterology; 2007; 54(73):36-40. PubMed ID: 17419227
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of CD44 expression in children with hepatoblastoma.
Cai HY; Yu B; Feng ZC; Qi X; Wei XJ
Genet Mol Res; 2015 Oct; 14(4):13203-7. PubMed ID: 26535633
[TBL] [Abstract][Full Text] [Related]
20. [Glypican 3 expression in hepatoblastoma and its diagnostic implication].
Wang FH; Wen JM; Vong HT; Yip YC
Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):806-9. PubMed ID: 24507097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
